25.04.2012
- U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers...
03.04.2012
- Amgen and British drugmaker AstraZeneca announced on Monday a major collaboration deal to jointly develop and sell five biotech drugs currently in Amgen's developmental pipeline...
01.08.2011
- Biotechnology firm Amgen has reported a 3% decline in its second-quarter profit as higher operating expenses offset increased product sales. However, adjusted earnings per share...
